Abstract
This review discusses the most active natural and synthetic compounds demonstrating the antimycobacterial activity at minimum inhibiting concentrations (MIC) of 5 μg/ml or less. For better insight into the “structure-activity” relationships, we occasionally considered compounds with high values of MIC. The review covers the period from 2001 to 2007. The data are grouped according to chemical structures, namely, nitrogen-, oxygen-, and sulfur-containing heterocyclic compounds, peptide, alkaloids, terpenoids, and others.
Keywords: Tuberculosis, multidrug-resistance tuberculosis, M. tuberculosis, antimycobacterial activity, antituberculosis activity, cytotoxicity, “structure-activity” relationships
Mini-Reviews in Organic Chemistry
Title: Natural and Synthetic Compounds with an Antimycobacterial Activity
Volume: 6 Issue: 2
Author(s): L. N. Rogoza, N. F. Salakhutdinov and G. A. Tolstikov
Affiliation:
Keywords: Tuberculosis, multidrug-resistance tuberculosis, M. tuberculosis, antimycobacterial activity, antituberculosis activity, cytotoxicity, “structure-activity” relationships
Abstract: This review discusses the most active natural and synthetic compounds demonstrating the antimycobacterial activity at minimum inhibiting concentrations (MIC) of 5 μg/ml or less. For better insight into the “structure-activity” relationships, we occasionally considered compounds with high values of MIC. The review covers the period from 2001 to 2007. The data are grouped according to chemical structures, namely, nitrogen-, oxygen-, and sulfur-containing heterocyclic compounds, peptide, alkaloids, terpenoids, and others.
Export Options
About this article
Cite this article as:
Rogoza N. L., Salakhutdinov F. N. and Tolstikov A. G., Natural and Synthetic Compounds with an Antimycobacterial Activity, Mini-Reviews in Organic Chemistry 2009; 6 (2) . https://dx.doi.org/10.2174/157019309788167657
DOI https://dx.doi.org/10.2174/157019309788167657 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Knowledge and Perceptions Towards Cardiovascular Disease Prevention Among Patients with Type 2 Diabetes Mellitus: A Review of Current Assessments and Recommendations
Current Diabetes Reviews Spinal Microvascular Expression of PV-1 is Associated with Inflammation, Perivascular Astrocyte Loss, and Diminished EC Glucose Transport Potential in Acute SCI
Current Neurovascular Research Meet Our Editorial Board Member:
Current Diabetes Reviews The Risk That DSM-5 Will Give Personality Dimensions A Bad Name
Current Psychiatry Reviews Inflammation, Microenvironment, and the Immune System in Cancer Progression
Current Pharmaceutical Design Securinine Derivatives as Potential Anti-amyloid Therapeutic Approach
CNS & Neurological Disorders - Drug Targets Urinary Metabolomics Reveals Alterations of Aromatic Amino Acid Metabolism of Alzheimer’s Disease in the Transgenic CRND8 Mice
Current Alzheimer Research Medical Treatment of Overactive Bladder: An Overview
Current Clinical Pharmacology Age Related Macular Degeneration and Visual Disability
Current Drug Targets Current Perspectives of Healthy Mitochondrial Function for Healthy Neurons
Current Drug Targets Role of Flavonoids in Neurodegenerative Disorders with Special Emphasis on Tangeritin
CNS & Neurological Disorders - Drug Targets Approach to the Patient with Subclinical Cushing’s Syndrome
Current Pharmaceutical Design Early Detection of Cerebral Glucose Uptake Changes in the 5XFAD Mouse
Current Alzheimer Research Targeting the JNK Pathway for Therapeutic Benefit in CNS Disease
Current Drug Targets - CNS & Neurological Disorders New Psychoactive Substances 3-Methoxyphencyclidine (3-MeO-PCP) and 3-Methoxyrolicyclidine (3-MeO-PCPy): Metabolic Fate Elucidated with Rat Urine and Human Liver Preparations and their Detectability in Urine by GC-MS, “LC-(High Resolution)-MSn” and “LC-(High Resolution)-MS/MS”
Current Neuropharmacology Molecular Mechanisms Involved in the Control of Neurohypophyseal Hormones Secretion
Current Pharmaceutical Design Chemokine-Chemokine Receptor Network in Immune Cell Trafficking
Current Drug Targets - Immune, Endocrine & Metabolic Disorders A Review of Titanium Di Oxide Nanoparticles - Synthesis, Applications and Toxicity Concerns
Nanoscience & Nanotechnology-Asia The TOLL-like / Type-I Interferon Pathways as Emerging Therapeutic Targets for Autoimmune Diseases
Drug Design Reviews - Online (Discontinued) Process, Outcomes and Possible Elimination of Aggregation with Special Reference to Heme Proteins; Likely Remediations of Proteinopathies
Current Protein & Peptide Science